Log in to save to my catalogue

Gene Signatures Distinguish Stage‐Specific Prostate Cancer Stem Cells Isolated From Transgenic Adeno...

Gene Signatures Distinguish Stage‐Specific Prostate Cancer Stem Cells Isolated From Transgenic Adeno...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3754468

Gene Signatures Distinguish Stage‐Specific Prostate Cancer Stem Cells Isolated From Transgenic Adenocarcinoma of the Mouse Prostate Lesions and Predict the Malignancy of Human Tumors

About this item

Full title

Gene Signatures Distinguish Stage‐Specific Prostate Cancer Stem Cells Isolated From Transgenic Adenocarcinoma of the Mouse Prostate Lesions and Predict the Malignancy of Human Tumors

Publisher

United States: AlphaMed Press

Journal title

Stem cells translational medicine, 2013-09, Vol.2 (9), p.678-689

Language

English

Formats

Publication information

Publisher

United States: AlphaMed Press

More information

Scope and Contents

Contents

This study established long‐term self‐renewing prostate cancer stem cell (PCSC) lines from the different stages of transgenic adenocarcinoma of the mouse prostate (TRAMP) progression by application of the neurosphere assay. It was found that TRAMP‐derived PCSCs represent a novel and valuable preclinical model for elucidating the pathogenetic mechan...

Alternative Titles

Full title

Gene Signatures Distinguish Stage‐Specific Prostate Cancer Stem Cells Isolated From Transgenic Adenocarcinoma of the Mouse Prostate Lesions and Predict the Malignancy of Human Tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3754468

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3754468

Other Identifiers

ISSN

2157-6564

E-ISSN

2157-6580

DOI

10.5966/sctm.2013-0041

How to access this item